China Gastrointestinal Cancer Drug Market Research Report 2018
The global Gastrointestinal Cancer Drug market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
China plays an important role in global market, with market size of xx million USD in 2016 and will be xx million USD in 2022, with a CAGR of xx%.
This report studies the Gastrointestinal Cancer Drug development status and future trend in China, focuses on top players in China, also splits Gastrointestinal Cancer Drug by type and by applications, to fully and deeply research and reveal the market general situation and future forecast.
The major players in China market include
China plays an important role in global market, with market size of xx million USD in 2016 and will be xx million USD in 2022, with a CAGR of xx%.
This report studies the Gastrointestinal Cancer Drug development status and future trend in China, focuses on top players in China, also splits Gastrointestinal Cancer Drug by type and by applications, to fully and deeply research and reveal the market general situation and future forecast.
The major players in China market include
- Celgene Corporation
- F. Hoffmann-La Roche Ltd.
- Eli Lilly and Company
- GlaxoSmithKline plc.
- Pfizer Inc.
- Sanofi
- Novartis AG.
- Bristol-Myers Squibb Company
- Amgen Limited & Amgen Ireland Limited
- Johnson & Johnson Private Limited
- South China
- East China
- Southwest China
- Northeast China
- North China
- Central China
- Northwest China
- By Therapy
- Immunotherapy
- Chemotherapy
- Targeted Therapy
- Radiation Therapy
- Hormone Therapy
- Adjuvant Chemotherapy
- By Route of Administration
- Oral
- Injectable Therapy
- Radiology
- Oncology
China Gastrointestinal Cancer Drug Market Research Report 2017
1 GASTROINTESTINAL CANCER DRUG OVERVIEW
1.1 Product Overview and Scope of Gastrointestinal Cancer Drug
1.2 Classification of Gastrointestinal Cancer Drug by Product Category
1.2.1 China Gastrointestinal Cancer Drug Sales (MT) Comparison by Type (2012-2022)
1.2.2 China Gastrointestinal Cancer Drug Sales (MT) Market Share by Type in 2016
1.2.3 Immunotherapy
1.2.4 Chemotherapy
1.2.5 Targeted Therapy
1.2.6 Radiation Therapy
1.2.7 Hormone Therapy
1.2.8 Adjuvant Chemotherapy
1.3 China Gastrointestinal Cancer Drug Market by Application/End Users
1.3.1 China Gastrointestinal Cancer Drug Sales (MT) and Market Share Comparison by Applications (2012-2022)
1.3.2 Radiology
1.3.3 Oncology
1.4 China Gastrointestinal Cancer Drug Market by Region
1.4.1 China Gastrointestinal Cancer Drug Market Size (Million USD) Comparison by Region (2012-2022)
1.4.2 South China Gastrointestinal Cancer Drug Status and Prospect (2012-2022)
1.4.3 East China Gastrointestinal Cancer Drug Status and Prospect (2012-2022)
1.4.4 Southwest China Gastrointestinal Cancer Drug Status and Prospect (2012-2022)
1.4.5 Northeast China Gastrointestinal Cancer Drug Status and Prospect (2012-2022)
1.4.6 North China Gastrointestinal Cancer Drug Status and Prospect (2012-2022)
1.4.7 Central China Gastrointestinal Cancer Drug Status and Prospect (2012-2022)
1.5 China Market Size (Sales and Revenue) of Gastrointestinal Cancer Drug (2012-2022)
1.5.1 China Gastrointestinal Cancer Drug Sales (MT) and Growth Rate (%)(2012-2022)
1.5.2 China Gastrointestinal Cancer Drug Revenue (Million USD) and Growth Rate (%)(2012-2022)
2 CHINA GASTROINTESTINAL CANCER DRUG MARKET COMPETITION BY PLAYERS/MANUFACTURERS
2.1 China Gastrointestinal Cancer Drug Sales and Market Share of Key Players/Manufacturers (2012-2017)
2.2 China Gastrointestinal Cancer Drug Revenue and Share by Players/Manufacturers (2012-2017)
2.3 China Gastrointestinal Cancer Drug Average Price (USD/Kg) by Players/Manufacturers (2012-2017)
2.4 China Gastrointestinal Cancer Drug Market Competitive Situation and Trends
2.4.1 China Gastrointestinal Cancer Drug Market Concentration Rate
2.4.2 China Gastrointestinal Cancer Drug Market Share of Top 3 and Top 5 Players/Manufacturers
2.4.3 Mergers & Acquisitions, Expansion in China Market
2.5 China Players/Manufacturers Gastrointestinal Cancer Drug Manufacturing Base Distribution, Sales Area, Product Types
3 CHINA GASTROINTESTINAL CANCER DRUG SALES AND REVENUE BY REGION (2012-2017)
3.1 China Gastrointestinal Cancer Drug Sales (MT) and Market Share by Region (2012-2017)
3.2 China Gastrointestinal Cancer Drug Revenue (Million USD) and Market Share by Region (2012-2017)
3.3 China Gastrointestinal Cancer Drug Price (USD/Kg) by Regions (2012-2017)
4 CHINA GASTROINTESTINAL CANCER DRUG SALES AND REVENUE BY TYPE/ PRODUCT CATEGORY (2012-2017)
4.1 China Gastrointestinal Cancer Drug Sales (MT) and Market Share by Type/ Product Category (2012-2017)
4.2 China Gastrointestinal Cancer Drug Revenue (Million USD) and Market Share by Type (2012-2017)
4.3 China Gastrointestinal Cancer Drug Price (USD/Kg) by Type (2012-2017)
4.4 China Gastrointestinal Cancer Drug Sales Growth Rate (%) by Type (2012-2017)
5 CHINA GASTROINTESTINAL CANCER DRUG SALES BY APPLICATION (2012-2017)
5.1 China Gastrointestinal Cancer Drug Sales (MT) and Market Share by Application (2012-2017)
5.2 China Gastrointestinal Cancer Drug Sales Growth Rate (%) by Application (2012-2017)
5.3 Market Drivers and Opportunities
6 CHINA GASTROINTESTINAL CANCER DRUG PLAYERS/SUPPLIERS PROFILES AND SALES DATA
6.1 Celgene Corporation
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Gastrointestinal Cancer Drug Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Celgene Corporation Gastrointestinal Cancer Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2012-2017)
6.1.4 Main Business/Business Overview
6.2 F. Hoffmann-La Roche Ltd.
6.2.1 Company Basic Information, Manufacturing Base and Competitors
6.2.2 Gastrointestinal Cancer Drug Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 F. Hoffmann-La Roche Ltd. Gastrointestinal Cancer Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2012-2017)
6.2.4 Main Business/Business Overview
6.3 Eli Lilly and Company
6.3.1 Company Basic Information, Manufacturing Base and Competitors
6.3.2 Gastrointestinal Cancer Drug Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Eli Lilly and Company Gastrointestinal Cancer Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2012-2017)
6.3.4 Main Business/Business Overview
6.4 GlaxoSmithKline plc.
6.4.1 Company Basic Information, Manufacturing Base and Competitors
6.4.2 Gastrointestinal Cancer Drug Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 GlaxoSmithKline plc. Gastrointestinal Cancer Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2012-2017)
6.4.4 Main Business/Business Overview
6.5 Pfizer Inc.
6.5.1 Company Basic Information, Manufacturing Base and Competitors
6.5.2 Gastrointestinal Cancer Drug Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Pfizer Inc. Gastrointestinal Cancer Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2012-2017)
6.5.4 Main Business/Business Overview
6.6 Sanofi
6.6.1 Company Basic Information, Manufacturing Base and Competitors
6.6.2 Gastrointestinal Cancer Drug Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Sanofi Gastrointestinal Cancer Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2012-2017)
6.6.4 Main Business/Business Overview
6.7 Novartis AG.
6.7.1 Company Basic Information, Manufacturing Base and Competitors
6.7.2 Gastrointestinal Cancer Drug Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Novartis AG. Gastrointestinal Cancer Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2012-2017)
6.7.4 Main Business/Business Overview
6.8 Bristol-Myers Squibb Company
6.8.1 Company Basic Information, Manufacturing Base and Competitors
6.8.2 Gastrointestinal Cancer Drug Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Bristol-Myers Squibb Company Gastrointestinal Cancer Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2012-2017)
6.8.4 Main Business/Business Overview
6.9 Amgen Limited & Amgen Ireland Limited
6.9.1 Company Basic Information, Manufacturing Base and Competitors
6.9.2 Gastrointestinal Cancer Drug Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Amgen Limited & Amgen Ireland Limited Gastrointestinal Cancer Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2012-2017)
6.9.4 Main Business/Business Overview
6.10 Johnson & Johnson Private Limited
6.10.1 Company Basic Information, Manufacturing Base and Competitors
6.10.2 Gastrointestinal Cancer Drug Product Category, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Johnson & Johnson Private Limited Gastrointestinal Cancer Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2012-2017)
6.10.4 Main Business/Business Overview
7 GASTROINTESTINAL CANCER DRUG MANUFACTURING COST ANALYSIS
7.1 Gastrointestinal Cancer Drug Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Gastrointestinal Cancer Drug
8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS
8.1 Gastrointestinal Cancer Drug Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Gastrointestinal Cancer Drug Major Manufacturers in 2016
8.4 Downstream Buyers
9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
10 MARKET EFFECT FACTORS ANALYSIS
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 CHINA GASTROINTESTINAL CANCER DRUG MARKET SIZE (SALES AND REVENUE) FORECAST (2017-2022)
11.1 China Gastrointestinal Cancer Drug Sales (MT), Revenue (Million USD) Forecast (2017-2022)
11.2 China Gastrointestinal Cancer Drug Sales (MT) Forecast by Type (2017-2022)
11.3 China Gastrointestinal Cancer Drug Sales (MT) Forecast by Application (2017-2022)
11.4 China Gastrointestinal Cancer Drug Sales (MT) Forecast by Region (2017-2022)
12 RESEARCH FINDINGS AND CONCLUSION
13 METHODOLOGY AND DATA SOURCE
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
The report requires updating with new data and is sent in 2-3 business days after order is placed.
List of Tables and Figures
Figure Global and China Market Size (Million USD) Comparison (2012-2022)
Table Gastrointestinal Cancer Drug Sales (MT) and Revenue (Million USD) Market Split by Product Type
Table Gastrointestinal Cancer Drug Sales (MT) by Application (2016-2022)
Figure Product Picture of Gastrointestinal Cancer Drug
Table China Gastrointestinal Cancer Drug Sales (MT) and Growth Rate (%) Comparison by Types (Product Category) (2012-2022)
Figure China Gastrointestinal Cancer Drug Sales Volume Market Share by Types in 2016
Figure Immunotherapy Product Picture
Figure Chemotherapy Product Picture
Figure Targeted Therapy Product Picture
Figure Radiation Therapy Product Picture
Figure Hormone Therapy Product Picture
Figure Adjuvant Chemotherapy Product Picture
Figure China Gastrointestinal Cancer Drug Sales (MT) Comparison by Application (2012-2022)
Figure China Sales Market Share (%) of Gastrointestinal Cancer Drug by Application in 2016
Figure Radiology Examples
Table Key Downstream Customer in Radiology
Figure Oncology Examples
Table Key Downstream Customer in Oncology
Figure South China Gastrointestinal Cancer Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure East China Gastrointestinal Cancer Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest China Gastrointestinal Cancer Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Northeast China Gastrointestinal Cancer Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure North China Gastrointestinal Cancer Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Central China Gastrointestinal Cancer Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Gastrointestinal Cancer Drug Sales (MT) and Growth Rate (%)(2012-2022)
Figure China Gastrointestinal Cancer Drug Revenue (Million USD) and Growth Rate (%)(2012-2022)
Table China Gastrointestinal Cancer Drug Sales of Key Players/Manufacturers (2012-2017)
Table China Gastrointestinal Cancer Drug Sales Share (%) by Players/Manufacturers (2012-2017)
Figure 2016 China Gastrointestinal Cancer Drug Sales Share (%) by Players/Manufacturers
Figure 2017 China Gastrointestinal Cancer Drug Sales Share (%) by Players/Manufacturers
Table China Gastrointestinal Cancer Drug Revenue by Players/Manufacturers (2012-2017)
Table China Gastrointestinal Cancer Drug Revenue Market Share (%) by Players/Manufacturers (2012-2017)
Figure 2016 China Gastrointestinal Cancer Drug Revenue Market Share (%) by Players/Manufacturers
Figure 2017 China Gastrointestinal Cancer Drug Revenue Market Share (%) by Players/Manufacturers
Table China Market Gastrointestinal Cancer Drug Average Price of Key Players/Manufacturers (2012-2017)
Figure China Market Gastrointestinal Cancer Drug Average Price of Key Players/Manufacturers in 2016
Figure China Gastrointestinal Cancer Drug Market Share of Top 3 Players/Manufacturers
Figure China Gastrointestinal Cancer Drug Market Share of Top 5 Players/Manufacturers
Table China Players/Manufacturers Gastrointestinal Cancer Drug Manufacturing Base Distribution and Sales Area
Table China Players/Manufacturers Gastrointestinal Cancer Drug Product Category
Table China Gastrointestinal Cancer Drug Sales (MT) by Regions (2012-2017)
Table China Gastrointestinal Cancer Drug Sales Share (%) by Regions (2012-2017)
Figure China Gastrointestinal Cancer Drug Sales Share (%) by Regions (2012-2017)
Figure China Gastrointestinal Cancer Drug Sales Market Share (%) by Regions in 2016
Table China Gastrointestinal Cancer Drug Revenue (Million USD) and Market Share by Regions (2012-2017)
Table China Gastrointestinal Cancer Drug Revenue Market Share (%) by Regions (2012-2017)
Figure China Gastrointestinal Cancer Drug Revenue Market Share (%) by Regions (2012-2017)
Figure China Gastrointestinal Cancer Drug Revenue Market Share (%) by Regions in 2016
Table China Gastrointestinal Cancer Drug Price (USD/Kg) by Regions (2012-2017)
Table China Gastrointestinal Cancer Drug Sales (MT) by Type (2012-2017)
Table China Gastrointestinal Cancer Drug Sales Share (%) by Type (2012-2017)
Figure China Gastrointestinal Cancer Drug Sales Share (%) by Type (2012-2017)
Figure China Gastrointestinal Cancer Drug Sales Market Share (%) by Type in 2016
Table China Gastrointestinal Cancer Drug Revenue (Million USD) and Market Share by Type (2012-2017)
Table China Gastrointestinal Cancer Drug Revenue Market Share (%) by Type (2012-2017)
Figure Revenue Market Share of Gastrointestinal Cancer Drug by Type (2012-2017)
Figure Revenue Market Share of Gastrointestinal Cancer Drug by Type in 2016
Table China Gastrointestinal Cancer Drug Price (USD/Kg) by Types (2012-2017)
Figure China Gastrointestinal Cancer Drug Sales Growth Rate (%) by Type (2012-2017)
Table China Gastrointestinal Cancer Drug Sales (MT) by Applications (2012-2017)
Table China Gastrointestinal Cancer Drug Sales Market Share (%) by Applications (2012-2017)
Figure China Gastrointestinal Cancer Drug Sales Market Share (%) by Application (2012-2017)
Figure China Gastrointestinal Cancer Drug Sales Market Share (%) by Application in 2016
Table China Gastrointestinal Cancer Drug Sales Growth Rate (%) by Application (2012-2017)
Figure China Gastrointestinal Cancer Drug Sales Growth Rate (%) by Application (2012-2017)
Table Celgene Corporation Gastrointestinal Cancer Drug Basic Information List
Table Celgene Corporation Gastrointestinal Cancer Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2012-2017)
Figure Celgene Corporation Gastrointestinal Cancer Drug Sales (MT) and Growth Rate (%)(2012-2017)
Figure Celgene Corporation Gastrointestinal Cancer Drug Sales Market Share (%) in China (2012-2017)
Figure Celgene Corporation Gastrointestinal Cancer Drug Revenue Market Share (%) in China (2012-2017)
Table F. Hoffmann-La Roche Ltd. Gastrointestinal Cancer Drug Basic Information List
Table F. Hoffmann-La Roche Ltd. Gastrointestinal Cancer Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2012-2017)
Figure F. Hoffmann-La Roche Ltd. Gastrointestinal Cancer Drug Sales (MT) and Growth Rate (%)(2012-2017)
Figure F. Hoffmann-La Roche Ltd. Gastrointestinal Cancer Drug Sales Market Share (%) in China (2012-2017)
Figure F. Hoffmann-La Roche Ltd. Gastrointestinal Cancer Drug Revenue Market Share (%) in China (2012-2017)
Table Eli Lilly and Company Gastrointestinal Cancer Drug Basic Information List
Table Eli Lilly and Company Gastrointestinal Cancer Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2012-2017)
Figure Eli Lilly and Company Gastrointestinal Cancer Drug Sales (MT) and Growth Rate (%)(2012-2017)
Figure Eli Lilly and Company Gastrointestinal Cancer Drug Sales Market Share (%) in China (2012-2017)
Figure Eli Lilly and Company Gastrointestinal Cancer Drug Revenue Market Share (%) in China (2012-2017)
Table GlaxoSmithKline plc. Gastrointestinal Cancer Drug Basic Information List
Table GlaxoSmithKline plc. Gastrointestinal Cancer Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2012-2017)
Figure GlaxoSmithKline plc. Gastrointestinal Cancer Drug Sales (MT) and Growth Rate (%)(2012-2017)
Figure GlaxoSmithKline plc. Gastrointestinal Cancer Drug Sales Market Share (%) in China (2012-2017)
Figure GlaxoSmithKline plc. Gastrointestinal Cancer Drug Revenue Market Share (%) in China (2012-2017)
Table Pfizer Inc. Gastrointestinal Cancer Drug Basic Information List
Table Pfizer Inc. Gastrointestinal Cancer Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2012-2017)
Figure Pfizer Inc. Gastrointestinal Cancer Drug Sales (MT) and Growth Rate (%)(2012-2017)
Figure Pfizer Inc. Gastrointestinal Cancer Drug Sales Market Share (%) in China (2012-2017)
Figure Pfizer Inc. Gastrointestinal Cancer Drug Revenue Market Share (%) in China (2012-2017)
Table Sanofi Gastrointestinal Cancer Drug Basic Information List
Table Sanofi Gastrointestinal Cancer Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2012-2017)
Figure Sanofi Gastrointestinal Cancer Drug Sales (MT) and Growth Rate (%)(2012-2017)
Figure Sanofi Gastrointestinal Cancer Drug Sales Market Share (%) in China (2012-2017)
Figure Sanofi Gastrointestinal Cancer Drug Revenue Market Share (%) in China (2012-2017)
Table Novartis AG. Gastrointestinal Cancer Drug Basic Information List
Table Novartis AG. Gastrointestinal Cancer Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2012-2017)
Figure Novartis AG. Gastrointestinal Cancer Drug Sales (MT) and Growth Rate (%)(2012-2017)
Figure Novartis AG. Gastrointestinal Cancer Drug Sales Market Share (%) in China (2012-2017)
Figure Novartis AG. Gastrointestinal Cancer Drug Revenue Market Share (%) in China (2012-2017)
Table Bristol-Myers Squibb Company Gastrointestinal Cancer Drug Basic Information List
Table Bristol-Myers Squibb Company Gastrointestinal Cancer Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2012-2017)
Figure Bristol-Myers Squibb Company Gastrointestinal Cancer Drug Sales (MT) and Growth Rate (%)(2012-2017)
Figure Bristol-Myers Squibb Company Gastrointestinal Cancer Drug Sales Market Share (%) in China (2012-2017)
Figure Bristol-Myers Squibb Company Gastrointestinal Cancer Drug Revenue Market Share (%) in China (2012-2017)
Table Amgen Limited & Amgen Ireland Limited Gastrointestinal Cancer Drug Basic Information List
Table Amgen Limited & Amgen Ireland Limited Gastrointestinal Cancer Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2012-2017)
Figure Amgen Limited & Amgen Ireland Limited Gastrointestinal Cancer Drug Sales (MT) and Growth Rate (%)(2012-2017)
Figure Amgen Limited & Amgen Ireland Limited Gastrointestinal Cancer Drug Sales Market Share (%) in China (2012-2017)
Figure Amgen Limited & Amgen Ireland Limited Gastrointestinal Cancer Drug Revenue Market Share (%) in China (2012-2017)
Table Johnson & Johnson Private Limited Gastrointestinal Cancer Drug Basic Information List
Table Johnson & Johnson Private Limited Gastrointestinal Cancer Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2012-2017)
Figure Johnson & Johnson Private Limited Gastrointestinal Cancer Drug Sales (MT) and Growth Rate (%)(2012-2017)
Figure Johnson & Johnson Private Limited Gastrointestinal Cancer Drug Sales Market Share (%) in China (2012-2017)
Figure Johnson & Johnson Private Limited Gastrointestinal Cancer Drug Revenue Market Share (%) in China (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Gastrointestinal Cancer Drug
Figure Manufacturing Process Analysis of Gastrointestinal Cancer Drug
Figure Gastrointestinal Cancer Drug Industrial Chain Analysis
Table Raw Materials Sources of Gastrointestinal Cancer Drug Major Players/Manufacturers in 2016
Table Major Buyers of Gastrointestinal Cancer Drug
Table Distributors/Traders List
Figure China Gastrointestinal Cancer Drug Sales (MT) and Growth Rate (%) Forecast (2017-2022)
Figure China Gastrointestinal Cancer Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure China Gastrointestinal Cancer Drug Price (USD/Kg) Trend Forecast (2017-2022)
Table China Gastrointestinal Cancer Drug Sales (MT) Forecast by Type (2017-2022)
Figure China Gastrointestinal Cancer Drug Sales (MT) Forecast by Type (2017-2022)
Figure China Gastrointestinal Cancer Drug Sales Volume Market Share Forecast by Type in 2022
Table China Gastrointestinal Cancer Drug Sales (MT) Forecast by Application (2017-2022)
Figure China Gastrointestinal Cancer Drug Sales Volume Market Share Forecast by Application (2017-2022)
Figure China Gastrointestinal Cancer Drug Sales Volume Market Share Forecast by Application in 2022
Table China Gastrointestinal Cancer Drug Sales (MT) Forecast by Regions (2017-2022)
Table China Gastrointestinal Cancer Drug Sales Volume Share Forecast by Regions (2017-2022)
Figure China Gastrointestinal Cancer Drug Sales Volume Share Forecast by Regions (2017-2022)
Figure China Gastrointestinal Cancer Drug Sales Volume Share Forecast by Regions in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
1 GASTROINTESTINAL CANCER DRUG OVERVIEW
1.1 Product Overview and Scope of Gastrointestinal Cancer Drug
1.2 Classification of Gastrointestinal Cancer Drug by Product Category
1.2.1 China Gastrointestinal Cancer Drug Sales (MT) Comparison by Type (2012-2022)
1.2.2 China Gastrointestinal Cancer Drug Sales (MT) Market Share by Type in 2016
1.2.3 Immunotherapy
1.2.4 Chemotherapy
1.2.5 Targeted Therapy
1.2.6 Radiation Therapy
1.2.7 Hormone Therapy
1.2.8 Adjuvant Chemotherapy
1.3 China Gastrointestinal Cancer Drug Market by Application/End Users
1.3.1 China Gastrointestinal Cancer Drug Sales (MT) and Market Share Comparison by Applications (2012-2022)
1.3.2 Radiology
1.3.3 Oncology
1.4 China Gastrointestinal Cancer Drug Market by Region
1.4.1 China Gastrointestinal Cancer Drug Market Size (Million USD) Comparison by Region (2012-2022)
1.4.2 South China Gastrointestinal Cancer Drug Status and Prospect (2012-2022)
1.4.3 East China Gastrointestinal Cancer Drug Status and Prospect (2012-2022)
1.4.4 Southwest China Gastrointestinal Cancer Drug Status and Prospect (2012-2022)
1.4.5 Northeast China Gastrointestinal Cancer Drug Status and Prospect (2012-2022)
1.4.6 North China Gastrointestinal Cancer Drug Status and Prospect (2012-2022)
1.4.7 Central China Gastrointestinal Cancer Drug Status and Prospect (2012-2022)
1.5 China Market Size (Sales and Revenue) of Gastrointestinal Cancer Drug (2012-2022)
1.5.1 China Gastrointestinal Cancer Drug Sales (MT) and Growth Rate (%)(2012-2022)
1.5.2 China Gastrointestinal Cancer Drug Revenue (Million USD) and Growth Rate (%)(2012-2022)
2 CHINA GASTROINTESTINAL CANCER DRUG MARKET COMPETITION BY PLAYERS/MANUFACTURERS
2.1 China Gastrointestinal Cancer Drug Sales and Market Share of Key Players/Manufacturers (2012-2017)
2.2 China Gastrointestinal Cancer Drug Revenue and Share by Players/Manufacturers (2012-2017)
2.3 China Gastrointestinal Cancer Drug Average Price (USD/Kg) by Players/Manufacturers (2012-2017)
2.4 China Gastrointestinal Cancer Drug Market Competitive Situation and Trends
2.4.1 China Gastrointestinal Cancer Drug Market Concentration Rate
2.4.2 China Gastrointestinal Cancer Drug Market Share of Top 3 and Top 5 Players/Manufacturers
2.4.3 Mergers & Acquisitions, Expansion in China Market
2.5 China Players/Manufacturers Gastrointestinal Cancer Drug Manufacturing Base Distribution, Sales Area, Product Types
3 CHINA GASTROINTESTINAL CANCER DRUG SALES AND REVENUE BY REGION (2012-2017)
3.1 China Gastrointestinal Cancer Drug Sales (MT) and Market Share by Region (2012-2017)
3.2 China Gastrointestinal Cancer Drug Revenue (Million USD) and Market Share by Region (2012-2017)
3.3 China Gastrointestinal Cancer Drug Price (USD/Kg) by Regions (2012-2017)
4 CHINA GASTROINTESTINAL CANCER DRUG SALES AND REVENUE BY TYPE/ PRODUCT CATEGORY (2012-2017)
4.1 China Gastrointestinal Cancer Drug Sales (MT) and Market Share by Type/ Product Category (2012-2017)
4.2 China Gastrointestinal Cancer Drug Revenue (Million USD) and Market Share by Type (2012-2017)
4.3 China Gastrointestinal Cancer Drug Price (USD/Kg) by Type (2012-2017)
4.4 China Gastrointestinal Cancer Drug Sales Growth Rate (%) by Type (2012-2017)
5 CHINA GASTROINTESTINAL CANCER DRUG SALES BY APPLICATION (2012-2017)
5.1 China Gastrointestinal Cancer Drug Sales (MT) and Market Share by Application (2012-2017)
5.2 China Gastrointestinal Cancer Drug Sales Growth Rate (%) by Application (2012-2017)
5.3 Market Drivers and Opportunities
6 CHINA GASTROINTESTINAL CANCER DRUG PLAYERS/SUPPLIERS PROFILES AND SALES DATA
6.1 Celgene Corporation
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Gastrointestinal Cancer Drug Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Celgene Corporation Gastrointestinal Cancer Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2012-2017)
6.1.4 Main Business/Business Overview
6.2 F. Hoffmann-La Roche Ltd.
6.2.1 Company Basic Information, Manufacturing Base and Competitors
6.2.2 Gastrointestinal Cancer Drug Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 F. Hoffmann-La Roche Ltd. Gastrointestinal Cancer Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2012-2017)
6.2.4 Main Business/Business Overview
6.3 Eli Lilly and Company
6.3.1 Company Basic Information, Manufacturing Base and Competitors
6.3.2 Gastrointestinal Cancer Drug Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Eli Lilly and Company Gastrointestinal Cancer Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2012-2017)
6.3.4 Main Business/Business Overview
6.4 GlaxoSmithKline plc.
6.4.1 Company Basic Information, Manufacturing Base and Competitors
6.4.2 Gastrointestinal Cancer Drug Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 GlaxoSmithKline plc. Gastrointestinal Cancer Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2012-2017)
6.4.4 Main Business/Business Overview
6.5 Pfizer Inc.
6.5.1 Company Basic Information, Manufacturing Base and Competitors
6.5.2 Gastrointestinal Cancer Drug Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Pfizer Inc. Gastrointestinal Cancer Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2012-2017)
6.5.4 Main Business/Business Overview
6.6 Sanofi
6.6.1 Company Basic Information, Manufacturing Base and Competitors
6.6.2 Gastrointestinal Cancer Drug Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Sanofi Gastrointestinal Cancer Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2012-2017)
6.6.4 Main Business/Business Overview
6.7 Novartis AG.
6.7.1 Company Basic Information, Manufacturing Base and Competitors
6.7.2 Gastrointestinal Cancer Drug Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Novartis AG. Gastrointestinal Cancer Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2012-2017)
6.7.4 Main Business/Business Overview
6.8 Bristol-Myers Squibb Company
6.8.1 Company Basic Information, Manufacturing Base and Competitors
6.8.2 Gastrointestinal Cancer Drug Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Bristol-Myers Squibb Company Gastrointestinal Cancer Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2012-2017)
6.8.4 Main Business/Business Overview
6.9 Amgen Limited & Amgen Ireland Limited
6.9.1 Company Basic Information, Manufacturing Base and Competitors
6.9.2 Gastrointestinal Cancer Drug Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Amgen Limited & Amgen Ireland Limited Gastrointestinal Cancer Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2012-2017)
6.9.4 Main Business/Business Overview
6.10 Johnson & Johnson Private Limited
6.10.1 Company Basic Information, Manufacturing Base and Competitors
6.10.2 Gastrointestinal Cancer Drug Product Category, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Johnson & Johnson Private Limited Gastrointestinal Cancer Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2012-2017)
6.10.4 Main Business/Business Overview
7 GASTROINTESTINAL CANCER DRUG MANUFACTURING COST ANALYSIS
7.1 Gastrointestinal Cancer Drug Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Gastrointestinal Cancer Drug
8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS
8.1 Gastrointestinal Cancer Drug Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Gastrointestinal Cancer Drug Major Manufacturers in 2016
8.4 Downstream Buyers
9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
10 MARKET EFFECT FACTORS ANALYSIS
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 CHINA GASTROINTESTINAL CANCER DRUG MARKET SIZE (SALES AND REVENUE) FORECAST (2017-2022)
11.1 China Gastrointestinal Cancer Drug Sales (MT), Revenue (Million USD) Forecast (2017-2022)
11.2 China Gastrointestinal Cancer Drug Sales (MT) Forecast by Type (2017-2022)
11.3 China Gastrointestinal Cancer Drug Sales (MT) Forecast by Application (2017-2022)
11.4 China Gastrointestinal Cancer Drug Sales (MT) Forecast by Region (2017-2022)
12 RESEARCH FINDINGS AND CONCLUSION
13 METHODOLOGY AND DATA SOURCE
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
The report requires updating with new data and is sent in 2-3 business days after order is placed.
List of Tables and Figures
Figure Global and China Market Size (Million USD) Comparison (2012-2022)
Table Gastrointestinal Cancer Drug Sales (MT) and Revenue (Million USD) Market Split by Product Type
Table Gastrointestinal Cancer Drug Sales (MT) by Application (2016-2022)
Figure Product Picture of Gastrointestinal Cancer Drug
Table China Gastrointestinal Cancer Drug Sales (MT) and Growth Rate (%) Comparison by Types (Product Category) (2012-2022)
Figure China Gastrointestinal Cancer Drug Sales Volume Market Share by Types in 2016
Figure Immunotherapy Product Picture
Figure Chemotherapy Product Picture
Figure Targeted Therapy Product Picture
Figure Radiation Therapy Product Picture
Figure Hormone Therapy Product Picture
Figure Adjuvant Chemotherapy Product Picture
Figure China Gastrointestinal Cancer Drug Sales (MT) Comparison by Application (2012-2022)
Figure China Sales Market Share (%) of Gastrointestinal Cancer Drug by Application in 2016
Figure Radiology Examples
Table Key Downstream Customer in Radiology
Figure Oncology Examples
Table Key Downstream Customer in Oncology
Figure South China Gastrointestinal Cancer Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure East China Gastrointestinal Cancer Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest China Gastrointestinal Cancer Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Northeast China Gastrointestinal Cancer Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure North China Gastrointestinal Cancer Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Central China Gastrointestinal Cancer Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Gastrointestinal Cancer Drug Sales (MT) and Growth Rate (%)(2012-2022)
Figure China Gastrointestinal Cancer Drug Revenue (Million USD) and Growth Rate (%)(2012-2022)
Table China Gastrointestinal Cancer Drug Sales of Key Players/Manufacturers (2012-2017)
Table China Gastrointestinal Cancer Drug Sales Share (%) by Players/Manufacturers (2012-2017)
Figure 2016 China Gastrointestinal Cancer Drug Sales Share (%) by Players/Manufacturers
Figure 2017 China Gastrointestinal Cancer Drug Sales Share (%) by Players/Manufacturers
Table China Gastrointestinal Cancer Drug Revenue by Players/Manufacturers (2012-2017)
Table China Gastrointestinal Cancer Drug Revenue Market Share (%) by Players/Manufacturers (2012-2017)
Figure 2016 China Gastrointestinal Cancer Drug Revenue Market Share (%) by Players/Manufacturers
Figure 2017 China Gastrointestinal Cancer Drug Revenue Market Share (%) by Players/Manufacturers
Table China Market Gastrointestinal Cancer Drug Average Price of Key Players/Manufacturers (2012-2017)
Figure China Market Gastrointestinal Cancer Drug Average Price of Key Players/Manufacturers in 2016
Figure China Gastrointestinal Cancer Drug Market Share of Top 3 Players/Manufacturers
Figure China Gastrointestinal Cancer Drug Market Share of Top 5 Players/Manufacturers
Table China Players/Manufacturers Gastrointestinal Cancer Drug Manufacturing Base Distribution and Sales Area
Table China Players/Manufacturers Gastrointestinal Cancer Drug Product Category
Table China Gastrointestinal Cancer Drug Sales (MT) by Regions (2012-2017)
Table China Gastrointestinal Cancer Drug Sales Share (%) by Regions (2012-2017)
Figure China Gastrointestinal Cancer Drug Sales Share (%) by Regions (2012-2017)
Figure China Gastrointestinal Cancer Drug Sales Market Share (%) by Regions in 2016
Table China Gastrointestinal Cancer Drug Revenue (Million USD) and Market Share by Regions (2012-2017)
Table China Gastrointestinal Cancer Drug Revenue Market Share (%) by Regions (2012-2017)
Figure China Gastrointestinal Cancer Drug Revenue Market Share (%) by Regions (2012-2017)
Figure China Gastrointestinal Cancer Drug Revenue Market Share (%) by Regions in 2016
Table China Gastrointestinal Cancer Drug Price (USD/Kg) by Regions (2012-2017)
Table China Gastrointestinal Cancer Drug Sales (MT) by Type (2012-2017)
Table China Gastrointestinal Cancer Drug Sales Share (%) by Type (2012-2017)
Figure China Gastrointestinal Cancer Drug Sales Share (%) by Type (2012-2017)
Figure China Gastrointestinal Cancer Drug Sales Market Share (%) by Type in 2016
Table China Gastrointestinal Cancer Drug Revenue (Million USD) and Market Share by Type (2012-2017)
Table China Gastrointestinal Cancer Drug Revenue Market Share (%) by Type (2012-2017)
Figure Revenue Market Share of Gastrointestinal Cancer Drug by Type (2012-2017)
Figure Revenue Market Share of Gastrointestinal Cancer Drug by Type in 2016
Table China Gastrointestinal Cancer Drug Price (USD/Kg) by Types (2012-2017)
Figure China Gastrointestinal Cancer Drug Sales Growth Rate (%) by Type (2012-2017)
Table China Gastrointestinal Cancer Drug Sales (MT) by Applications (2012-2017)
Table China Gastrointestinal Cancer Drug Sales Market Share (%) by Applications (2012-2017)
Figure China Gastrointestinal Cancer Drug Sales Market Share (%) by Application (2012-2017)
Figure China Gastrointestinal Cancer Drug Sales Market Share (%) by Application in 2016
Table China Gastrointestinal Cancer Drug Sales Growth Rate (%) by Application (2012-2017)
Figure China Gastrointestinal Cancer Drug Sales Growth Rate (%) by Application (2012-2017)
Table Celgene Corporation Gastrointestinal Cancer Drug Basic Information List
Table Celgene Corporation Gastrointestinal Cancer Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2012-2017)
Figure Celgene Corporation Gastrointestinal Cancer Drug Sales (MT) and Growth Rate (%)(2012-2017)
Figure Celgene Corporation Gastrointestinal Cancer Drug Sales Market Share (%) in China (2012-2017)
Figure Celgene Corporation Gastrointestinal Cancer Drug Revenue Market Share (%) in China (2012-2017)
Table F. Hoffmann-La Roche Ltd. Gastrointestinal Cancer Drug Basic Information List
Table F. Hoffmann-La Roche Ltd. Gastrointestinal Cancer Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2012-2017)
Figure F. Hoffmann-La Roche Ltd. Gastrointestinal Cancer Drug Sales (MT) and Growth Rate (%)(2012-2017)
Figure F. Hoffmann-La Roche Ltd. Gastrointestinal Cancer Drug Sales Market Share (%) in China (2012-2017)
Figure F. Hoffmann-La Roche Ltd. Gastrointestinal Cancer Drug Revenue Market Share (%) in China (2012-2017)
Table Eli Lilly and Company Gastrointestinal Cancer Drug Basic Information List
Table Eli Lilly and Company Gastrointestinal Cancer Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2012-2017)
Figure Eli Lilly and Company Gastrointestinal Cancer Drug Sales (MT) and Growth Rate (%)(2012-2017)
Figure Eli Lilly and Company Gastrointestinal Cancer Drug Sales Market Share (%) in China (2012-2017)
Figure Eli Lilly and Company Gastrointestinal Cancer Drug Revenue Market Share (%) in China (2012-2017)
Table GlaxoSmithKline plc. Gastrointestinal Cancer Drug Basic Information List
Table GlaxoSmithKline plc. Gastrointestinal Cancer Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2012-2017)
Figure GlaxoSmithKline plc. Gastrointestinal Cancer Drug Sales (MT) and Growth Rate (%)(2012-2017)
Figure GlaxoSmithKline plc. Gastrointestinal Cancer Drug Sales Market Share (%) in China (2012-2017)
Figure GlaxoSmithKline plc. Gastrointestinal Cancer Drug Revenue Market Share (%) in China (2012-2017)
Table Pfizer Inc. Gastrointestinal Cancer Drug Basic Information List
Table Pfizer Inc. Gastrointestinal Cancer Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2012-2017)
Figure Pfizer Inc. Gastrointestinal Cancer Drug Sales (MT) and Growth Rate (%)(2012-2017)
Figure Pfizer Inc. Gastrointestinal Cancer Drug Sales Market Share (%) in China (2012-2017)
Figure Pfizer Inc. Gastrointestinal Cancer Drug Revenue Market Share (%) in China (2012-2017)
Table Sanofi Gastrointestinal Cancer Drug Basic Information List
Table Sanofi Gastrointestinal Cancer Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2012-2017)
Figure Sanofi Gastrointestinal Cancer Drug Sales (MT) and Growth Rate (%)(2012-2017)
Figure Sanofi Gastrointestinal Cancer Drug Sales Market Share (%) in China (2012-2017)
Figure Sanofi Gastrointestinal Cancer Drug Revenue Market Share (%) in China (2012-2017)
Table Novartis AG. Gastrointestinal Cancer Drug Basic Information List
Table Novartis AG. Gastrointestinal Cancer Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2012-2017)
Figure Novartis AG. Gastrointestinal Cancer Drug Sales (MT) and Growth Rate (%)(2012-2017)
Figure Novartis AG. Gastrointestinal Cancer Drug Sales Market Share (%) in China (2012-2017)
Figure Novartis AG. Gastrointestinal Cancer Drug Revenue Market Share (%) in China (2012-2017)
Table Bristol-Myers Squibb Company Gastrointestinal Cancer Drug Basic Information List
Table Bristol-Myers Squibb Company Gastrointestinal Cancer Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2012-2017)
Figure Bristol-Myers Squibb Company Gastrointestinal Cancer Drug Sales (MT) and Growth Rate (%)(2012-2017)
Figure Bristol-Myers Squibb Company Gastrointestinal Cancer Drug Sales Market Share (%) in China (2012-2017)
Figure Bristol-Myers Squibb Company Gastrointestinal Cancer Drug Revenue Market Share (%) in China (2012-2017)
Table Amgen Limited & Amgen Ireland Limited Gastrointestinal Cancer Drug Basic Information List
Table Amgen Limited & Amgen Ireland Limited Gastrointestinal Cancer Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2012-2017)
Figure Amgen Limited & Amgen Ireland Limited Gastrointestinal Cancer Drug Sales (MT) and Growth Rate (%)(2012-2017)
Figure Amgen Limited & Amgen Ireland Limited Gastrointestinal Cancer Drug Sales Market Share (%) in China (2012-2017)
Figure Amgen Limited & Amgen Ireland Limited Gastrointestinal Cancer Drug Revenue Market Share (%) in China (2012-2017)
Table Johnson & Johnson Private Limited Gastrointestinal Cancer Drug Basic Information List
Table Johnson & Johnson Private Limited Gastrointestinal Cancer Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2012-2017)
Figure Johnson & Johnson Private Limited Gastrointestinal Cancer Drug Sales (MT) and Growth Rate (%)(2012-2017)
Figure Johnson & Johnson Private Limited Gastrointestinal Cancer Drug Sales Market Share (%) in China (2012-2017)
Figure Johnson & Johnson Private Limited Gastrointestinal Cancer Drug Revenue Market Share (%) in China (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Gastrointestinal Cancer Drug
Figure Manufacturing Process Analysis of Gastrointestinal Cancer Drug
Figure Gastrointestinal Cancer Drug Industrial Chain Analysis
Table Raw Materials Sources of Gastrointestinal Cancer Drug Major Players/Manufacturers in 2016
Table Major Buyers of Gastrointestinal Cancer Drug
Table Distributors/Traders List
Figure China Gastrointestinal Cancer Drug Sales (MT) and Growth Rate (%) Forecast (2017-2022)
Figure China Gastrointestinal Cancer Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure China Gastrointestinal Cancer Drug Price (USD/Kg) Trend Forecast (2017-2022)
Table China Gastrointestinal Cancer Drug Sales (MT) Forecast by Type (2017-2022)
Figure China Gastrointestinal Cancer Drug Sales (MT) Forecast by Type (2017-2022)
Figure China Gastrointestinal Cancer Drug Sales Volume Market Share Forecast by Type in 2022
Table China Gastrointestinal Cancer Drug Sales (MT) Forecast by Application (2017-2022)
Figure China Gastrointestinal Cancer Drug Sales Volume Market Share Forecast by Application (2017-2022)
Figure China Gastrointestinal Cancer Drug Sales Volume Market Share Forecast by Application in 2022
Table China Gastrointestinal Cancer Drug Sales (MT) Forecast by Regions (2017-2022)
Table China Gastrointestinal Cancer Drug Sales Volume Share Forecast by Regions (2017-2022)
Figure China Gastrointestinal Cancer Drug Sales Volume Share Forecast by Regions (2017-2022)
Figure China Gastrointestinal Cancer Drug Sales Volume Share Forecast by Regions in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
